Case File
efta-01461013DOJ Data Set 10OtherEFTA01461013
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01461013
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Todd Stevens j
]
Sent:
1/20/2016 2:24:20 PM
To:
Chip Packard
Subject:
FW: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval IC] [I]
Classification: For Internal use only
Are you supportive of this account opening?
From: Wayne Salit
Sent: Tuesday, January 19, 2016 2:10 PM
To: Daniel Sabba
Cc: Todd Stevens; Chip Packard; Jan Bornebusch
Subject: RE: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C] [I]
Classification: For Internal use only
Dan -
As we discussed, I do not have any further guidance on whether ARRC would permit a new brokerage account for Mr.
Epstein or not. I suggest you reach to Carol Saracco from the ARRC to get more detail on the parameters of the their
guidance in the e-mail date Feb 6, 2015 below. Specifically, does the proposed new brokerage account for one of Mr.
Epstein's entities require bringing this matter back to ARRC.
Kind Regards,
Wayne Salit
Deutsche Bank Americas
(ph)
From: Daniel Sabba
Sent: Tuesday, January 19, 2016 1:49 PM
To: Daniel Sabba; Wayne Salit
Cc: Todd Stevens; Chip Packard
Subject: RE: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C]
Hi Wayne — I tried to call and got voice mail. We wanted to follow-up on this matter - the client continues to inquire
about the opening of this account. Regards, Daniel
From: Daniel Sabba
Sent: Wednesday, January 13, 2016 2:17 PM
To: Wayne Salit
Cc: Todd Stevens; Chip Packard
Subject: FW: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C]
Wayne — I hope all is well. Jeffrey Epstein's CFO has requested the opening of a new DBSI account for one of his entities
(Gratitude America, Ltd. — see attached). We would like to get clarity on whether this can be done with the approvals we
have in place or whether this has to be brought to the RRC. Please see below on guidance we received from Jan Ford on
this matter early last year after it was brought for the committee's consideration. Can you please advise on this matter?
From: Daniel Sabba
Sent: Friday, January 08, 2016 10:02 AM
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 122800
CONFIDENTIAL
SDNY_GM_00268984
EFTA01461013
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.